ZD

Ziff Davis, Inc. ZD · NASDAQ

$57.15 -2.21% (-$1.29)

Summary

69 / 100 · Bulios Score

What speaks for it

  • Out of every 100 USD of revenue, 49 USD is left as net profit.
  • It holds more cash than debt: $1.61B against $867.6M.
  • The share price is below the Bulios Fair Price.
  • It bought back its own shares for $173.8M in the last fiscal year, 8.1% of its market value.

What to watch

  • Operating profit does not even cover the interest on its debt.
  • Earnings per share fell by 5.4% a year over the last 3 years.
  • It earns only 3.6 USD a year on every 100 USD of invested capital.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price $57.15
5-year average P/E 42.6 92% lower
P/E today 3.3
Advertising Agencies industry median
P/E today 3.3

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 3.3 USD for 1 USD of yearly profit. Over the last five years it was 42.6 USD on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 4.6% a year over 5 years. Over the last 3 years it grew by 1.4% a year. Earnings per share fell by 5.4% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 USD of revenue goes

Net profit, industry median (Advertising Agencies) 2.5 USD

Out of every 100 USD of revenue, 49 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

Repaying all its debt would take 2.7 years of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $61.5 is 7.6% above today's price. 62% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

Health and Wellness brings in 28% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.